Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Schrodinger Inc (SDGR)

Schrodinger Inc (SDGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,329,653
  • Shares Outstanding, K 73,665
  • Annual Sales, $ 207,540 K
  • Annual Income, $ -187,120 K
  • EBIT $ -170 M
  • EBITDA $ -164 M
  • 60-Month Beta 1.56
  • Price/Sales 6.44
  • Price/Cash Flow N/A
  • Price/Book 4.16

Options Overview Details

View History
  • Implied Volatility 55.09% (-3.88%)
  • Historical Volatility 41.80%
  • IV Percentile 18%
  • IV Rank 13.13%
  • IV High 98.58% on 04/08/25
  • IV Low 48.51% on 12/30/24
  • Expected Move (DTE 4) 1.02 (5.65%)
  • Put/Call Vol Ratio 0.05
  • Today's Volume 1,337
  • Volume Avg (30-Day) 442
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 39,014
  • Open Int (30-Day) 39,218
  • Expected Range 17.03 to 19.07

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.02
  • Number of Estimates 2
  • High Estimate 0.13
  • Low Estimate -0.09
  • Prior Year -0.55
  • Growth Rate Est. (year over year) +103.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.99 +12.88%
on 11/21/25
18.88 -4.40%
on 12/12/25
+0.07 (+0.39%)
since 11/12/25
3-Month
15.99 +12.88%
on 11/21/25
23.02 -21.59%
on 10/27/25
-0.52 (-2.80%)
since 09/12/25
52-Week
15.99 +12.88%
on 11/21/25
28.47 -36.60%
on 02/18/25
-3.02 (-14.33%)
since 12/12/24

Most Recent Stories

More News
Schrödinger to Present at Jefferies London Healthcare Conference

Schrödinger , Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Jefferies London Healthcare Conference. The live presentation will take place on Wednesday,...

SDGR : 18.05 (-0.44%)
Schrödinger Reports Third Quarter 2025 Financial Results

Third Quarter Total Revenue of $54.3 Million, Software Revenue of $40.9 Million Updates 2025 Financial Guidance

SDGR : 18.05 (-0.44%)
Schrödinger to Announce Third Quarter 2025 Financial Results on November 5

Schrödinger (Nasdaq: SDGR) will report its third quarter 2025 financial results on Wednesday, November 5, 2025, after the financial markets close. The company will host a conference call and webcast at...

SDGR : 18.05 (-0.44%)
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger, Inc. (Nasdaq: SDGR) today reported that on October 13, 2025, the company granted restricted stock units (RSUs) with respect to 14,888 shares of the company’s common stock to 10 newly hired...

SDGR : 18.05 (-0.44%)
Craig-Hallum Sticks to Their Buy Rating for Schrodinger (SDGR)

Craig-Hallum analyst Matt Hewitt maintained a Buy rating on Schrodinger today. The company’s shares opened today at $21.33.Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off!...

SDGR : 18.05 (-0.44%)
Analysts’ Top Healthcare Picks: Arvinas Holding Company (ARVN), Schrodinger (SDGR)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Arvinas Holding Company (ARVN – Research Report) and Schrodinger (SDGR – Research Report) with bullish...

ARVN : 12.58 (+0.08%)
SDGR : 18.05 (-0.44%)
Craig-Hallum Keeps Their Buy Rating on Schrodinger (SDGR)

Craig-Hallum analyst Matt Hewitt maintained a Buy rating on Schrodinger today. The company’s shares closed yesterday at $21.21.Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55%...

SDGR : 18.05 (-0.44%)
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger, Inc. (Nasdaq: SDGR) today reported that on September 14, 2025, the company granted restricted stock units (RSUs) with respect to 1,666 shares of the company’s common stock to four newly...

SDGR : 18.05 (-0.44%)
I Asked ChatGPT’s Most Advanced Model to Find the Stocks Most Likely to 100x Over the Next 10 Years — Here’s What It Said

Here are the stocks that ChatGPT's most advanced model says are most likely to 100x over the next 10 years.

NVDA : 175.02 (-3.27%)
SLDP : 4.91 (-5.58%)
AI : 15.27 (-4.08%)
RKLB : 61.49 (-3.21%)
RXRX : 4.33 (-5.46%)
IONQ : 50.35 (-4.19%)
NNDM : 1.7700 (-0.56%)
ASTS : 76.70 (-9.50%)
ORGN : 0.4131 (-6.75%)
ARQQ : 28.35 (-4.55%)
AEHR : 24.48 (-7.38%)
ABCL : 3.62 (-3.21%)
Schrödinger to Present at Morgan Stanley Global Healthcare Conference

Schrödinger , Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference. The live presentation will...

SDGR : 18.05 (-0.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

Schr'dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr'dinger Inc. is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 19.69
2nd Resistance Point 19.28
1st Resistance Point 18.67
Last Price 18.05
1st Support Level 17.65
2nd Support Level 17.24
3rd Support Level 16.63

See More

52-Week High 28.47
Fibonacci 61.8% 23.70
Fibonacci 50% 22.23
Fibonacci 38.2% 20.76
Last Price 18.05
52-Week Low 15.99

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar